Vijaya Diagnostic Centre Ltd (VIJAYA) Q1FY27 Management Mirror - Jun-2026 Qtr
Q1 FY27 EBITDA Margin Reported at 42.7%, Sustaining Above 40%+ Prior Guidance; Long-Term Target Reaffirmed
Management's margin expectations have remained consistent. In the Dec'25 Qtr concall, forward EBITDA margin guidance was maintained at 40%. In the Mar'26 Qtr concall, management set a conservative FY27 EBITDA margin guidance of 40%+ to accommodate startup costs and investments. This target was reaffirmed in the Jun'26 Qtr concall, where management expects operating leverage to sustain EBITDA margins above the 40.0% threshold. For Q1 FY27, the EBITDA margin was reported at 42.7% in the Quarterly Financial Results (and similarly noted at 42.7% in the Jun'26 Qtr concall).
3 more themes on the ELITE plan.